Marketing-authorisation holder ยท Canada
Bayer Inc
316 medicines in 1 country, as authorisation holder.
Loadingโฆ
Marketing-authorisation holder ยท Canada
316 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1โ25 of 316
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADALAT XL30 mg ยท Tablet (Extended-Release) | Nifedipine | Canada | Marketed | 1992 |
| ADEMPAS2.5 mg ยท Tablet | Riociguat | Canada | Marketed | 2013 |
| ADEMPAS2 mg ยท Tablet | Riociguat | Canada | Marketed | 2013 |
| ADEMPAS1 mg ยท Tablet | Riociguat | Canada | Marketed | 2013 |
| ADEMPAS1.5 mg ยท Tablet | Riociguat | Canada | Marketed | 2013 |
| ADEMPAS0.5 mg ยท Tablet | Riociguat | Canada | Marketed | 2013 |
| AERIUS0.5 mg / ml ยท Syrup | Desloratadine | Canada | Authorised | |
| AERIUS5 mg ยท Tablet | Desloratadine | Canada | Marketed | 2002 |
| AERIUS KIDS0.5 mg / ml ยท Syrup | Desloratadine | Canada | Marketed | 2005 |
| AERIUS SINUS + ALLERGY2.5 mg + 120 mg ยท Tablet (Extended-Release) | Desloratadine, Pseudoephedrine | Canada | Marketed | 2010 |
| AESB - OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION USP, 0.025%0.025 % ยท Solution | Oxymetazoline | Canada | Authorised | |
| ALEVE BACK AND BODY PAIN220 mg ยท Capsule | Naproxen | Canada | Marketed | 2015 |
| ALEVE CAPLETS220 mg ยท Tablet | Naproxen | Canada | Marketed | 2009 |
| ALEVE LIQUID GELS220 mg ยท Capsule | Naproxen | Canada | Marketed | 2011 |
| ALEVE NIGHTTIME25 mg + 220 mg ยท Tablet | Diphenhydramine, Naproxen | Canada | Marketed | 2016 |
| AMBELVIST257.9 mg / ml ยท Solution | Gadoquatrane | Canada | Authorised | |
| ANGELIQ1.0 mg + 1.0 mg ยท Tablet | Drospirenona, Estradiol | Canada | Marketed | 2008 |
| ASPIRIN 81MG81 mg ยท Tablet (Enteric-Coated) | Acetylsalicylic acid | Canada | Marketed | 1998 |
| ASPIRIN 81MG QUICK CHEWS81 mg ยท Tablet (Chewable) | Acetylsalicylic acid | Canada | Marketed | 2007 |
| ASPIRIN COATED FOR DELAYED RELEASE REGULAR STRENGTH325 mg ยท Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Marketed | 1995 |
| ASPIRIN EXTRA STRENGTH500 mg ยท Tablet | Acetylsalicylic acid | Canada | Marketed | 1995 |
| ASPIRIN REGULAR STRENGTH325 mg ยท Tablet | Acetylsalicylic acid | Canada | Marketed | 1970 |
| BETASERON0.3 mg / vial ยท Powder For Solution | Interferon beta-1a | Canada | Marketed | 1995 |
| CANESORAL150 mg ยท Capsule | Fluconazole | Canada | Marketed | 2010 |
| CANESORAL COMBI 1 DAY2 % / w/w + 150 mg / cap ยท Capsule, Cream | Clotrimazole, Fluconazole | Canada | Marketed | 2020 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 316 | 128 | 188 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Keep Bayer Incโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.
Ranked by their number of medicines.